This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JOHN B. YOUMANS, M.D.; R. H. KAMPMEIER, M.D.

Arch Intern Med. 1928;41(1):66-74.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In recent years there has developed a general belief that so-called adenomatous goiter with hyperthroidism (toxic adenoma) and exophthalmic goiter are two separate diseases. Still more recently, this belief has been emphasized by the common acceptance of the view that iodine, though beneficial under certain conditions in exophthalmic goiter, is harmful to and contraindicated in cases of toxic adenoma. Such a difference in response to iodine might well be expected to occur were it true that a fundamental difference exists between these two types of thyrotoxicosis. However, conclusive evidence of such a difference has not been presented, and it seemed that further evidence concerning the nature of toxic adenoma would be obtained by a trial of the effect of iodine in such cases. Such a study could be expected to furnish further evidence of the relation existing between exophthalmic goiter and toxic adenoma. In 1924, we therefore began a study . . . [Full Text PDF of this Article]

Author Affiliations
ANN ARBOR, MICH.

From the Department of Internal Medicine, University of Michigan Medical School.

Footnotes
Read in abstract at the meeting of the American Society for Clinical Investigation, Atlantic City, May 2, 1927.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?